Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Gastric Cancer

  Free Subscription


Articles published in BMC Cancer

Retrieve available abstracts of 90 articles:
HTML format
Text format



Single Articles


    March 2017
  1. WANG H, Lu J, Tang J, Chen S, et al
    Establishment of patient-derived gastric cancer xenografts: a useful tool for preclinical evaluation of targeted therapies involving alterations in HER-2, MET and FGFR2 signaling pathways.
    BMC Cancer. 2017;17:191.
    PubMed     Text format     Abstract available


  2. LIU X, Guo W, Zhang W, Yin J, et al
    A multi-center phase II study and biomarker analysis of combined cetuximab and modified FOLFIRI as second-line treatment in patients with metastatic gastric cancer.
    BMC Cancer. 2017;17:188.
    PubMed     Text format     Abstract available


  3. LEE JW, Choi MH, Lee YJ, Ali B, et al
    Radiofrequency ablation for liver metastases in patients with gastric cancer as an alternative to hepatic resection.
    BMC Cancer. 2017;17:185.
    PubMed     Text format     Abstract available


  4. HAMASHIMA C, Sasazuki S, Inoue M, Tsugane S, et al
    Receiver operating characteristic analysis of prediction for gastric cancer development using serum pepsinogen and Helicobacter pylori antibody tests.
    BMC Cancer. 2017;17:183.
    PubMed     Text format     Abstract available


    February 2017
  5. LOZANO-POPE I, Sharma A, Matthias M, Doran KS, et al
    Effect of myeloid differentiation primary response gene 88 on expression profiles of genes during the development and progression of Helicobacter-induced gastric cancer.
    BMC Cancer. 2017;17:133.
    PubMed     Text format     Abstract available


  6. YU B, Chen X, Li J, Gu Q, et al
    microRNA-29c inhibits cell proliferation by targeting NASP in human gastric cancer.
    BMC Cancer. 2017;17:109.
    PubMed     Text format     Abstract available


    January 2017
  7. HUR H, Ham IH, Lee D, Jin H, et al
    Discoidin domain receptor 1 activity drives an aggressive phenotype in gastric carcinoma.
    BMC Cancer. 2017;17:87.
    PubMed     Text format     Abstract available


  8. DIAO D, Cheng Y, Song Y, Zhang H, et al
    D-dimer is an essential accompaniment of circulating tumor cells in gastric cancer.
    BMC Cancer. 2017;17:56.
    PubMed     Text format     Abstract available


  9. OKAZAKI M, Fushida S, Harada S, Tsukada T, et al
    Establishing a xenograft mouse model of peritoneal dissemination of gastric cancer with organ invasion and fibrosis.
    BMC Cancer. 2017;17:23.
    PubMed     Text format     Abstract available


  10. SONG H, Fang F, Valdimarsdottir U, Lu D, et al
    Waiting time for cancer treatment and mental health among patients with newly diagnosed esophageal or gastric cancer: a nationwide cohort study.
    BMC Cancer. 2017;17:2.
    PubMed     Text format     Abstract available


    December 2016
  11. PU WY, Zhang R, Xiao L, Wu YY, et al
    Prediction of cancer progression in a group of 73 gastric cancer patients by circulating cell-free DNA.
    BMC Cancer. 2016;16:943.
    PubMed     Text format     Abstract available


  12. HOFHEINZ R, Clouth J, Borchardt-Wagner J, Wagner U, et al
    Patient preferences for palliative treatment of locally advanced or metastatic gastric cancer and adenocarcinoma of the gastroesophageal junction: a choice-based conjoint analysis study from Germany.
    BMC Cancer. 2016;16:937.
    PubMed     Text format     Abstract available


    November 2016
  13. SEO SH, Kim SE, Kang YK, Ryoo BY, et al
    Association of nutritional status-related indices and chemotherapy-induced adverse events in gastric cancer patients.
    BMC Cancer. 2016;16:900.
    PubMed     Text format     Abstract available


    October 2016
  14. FENG M, Yao G, Yu H, Qing Y, et al
    Tumor apelin, not serum apelin, is associated with the clinical features and prognosis of gastric cancer.
    BMC Cancer. 2016;16:794.
    PubMed     Text format     Abstract available


  15. JI X, Fu T, Bu ZD, Zhang J, et al
    Comparison of different methods of splenic hilar lymph node dissection for advanced upper- and/or middle-third gastric cancer.
    BMC Cancer. 2016;16:765.
    PubMed     Text format     Abstract available


    January 2016
  16. KUPCINSKAITE-NOREIKIENE R, Ugenskiene R, Noreika A, Rudzianskas V, et al
    Gene methylation profile of gastric cancerous tissue according to tumor site in the stomach.
    BMC Cancer. 2016;16:40.
    PubMed     Text format     Abstract available


  17. LI SX, Seo SH, Choi YY, Nakagawa M, et al
    Correlation analyses between pre- and post-operative adverse events in gastric cancer patients receiving preoperative treatment and gastrectomy.
    BMC Cancer. 2016;16:29.
    PubMed     Text format     Abstract available


  18. ITO K, Mitsunaga M, Arihiro S, Saruta M, et al
    Molecular targeted photoimmunotherapy for HER2-positive human gastric cancer in combination with chemotherapy results in improved treatment outcomes through different cytotoxic mechanisms.
    BMC Cancer. 2016;16:37.
    PubMed     Text format     Abstract available


  19. PARK CH, Cho SY, Ha JD, Jung H, et al
    Novel c-Met inhibitor suppresses the growth of c-Met-addicted gastric cancer cells.
    BMC Cancer. 2016;16:35.
    PubMed     Text format     Abstract available


  20. CHANG HR, Park HS, Ahn YZ, Nam S, et al
    Improving gastric cancer preclinical studies using diverse in vitro and in vivo model systems.
    BMC Cancer. 2016;16:200.
    PubMed     Text format     Abstract available


  21. EFTANG LL, Klajic J, Kristensen VN, Tost J, et al
    GFRA3 promoter methylation may be associated with decreased postoperative survival in gastric cancer.
    BMC Cancer. 2016;16:225.
    PubMed     Text format     Abstract available


  22. LIU N, Zhou N, Chai N, Liu X, et al
    Helicobacter pylori promotes angiogenesis depending on Wnt/beta-catenin-mediated vascular endothelial growth factor via the cyclooxygenase-2 pathway in gastric cancer.
    BMC Cancer. 2016;16:321.
    PubMed     Text format     Abstract available


  23. PARK JY, Kim YW, Ryu KW, Nam BH, et al
    Assessment of laparoscopic stomach preserving surgery with sentinel basin dissection versus standard gastrectomy with lymphadenectomy in early gastric cancer-A multicenter randomized phase III clinical trial (SENORITA trial) protocol.
    BMC Cancer. 2016;16:340.
    PubMed     Text format     Abstract available


  24. HARADA K, Baba Y, Shigaki H, Ishimoto T, et al
    Prognostic and clinical impact of PIK3CA mutation in gastric cancer: pyrosequencing technology and literature review.
    BMC Cancer. 2016;16:400.
    PubMed     Text format     Abstract available


  25. LIM SM, Kim YN, Park KH, Kang B, et al
    Bone alkaline phosphatase as a surrogate marker of bone metastasis in gastric cancer patients.
    BMC Cancer. 2016;16:385.
    PubMed     Text format     Abstract available


  26. WANG H, Zhang H, Deng P, Liu C, et al
    Tissue metabolic profiling of human gastric cancer assessed by (1)H NMR.
    BMC Cancer. 2016;16:371.
    PubMed     Text format     Abstract available


  27. YU X, Hu F, Yao Q, Li C, et al
    Serum fibrinogen levels are positively correlated with advanced tumor stage and poor survival in patients with gastric cancer undergoing gastrectomy: a large cohort retrospective study.
    BMC Cancer. 2016;16:480.
    PubMed     Text format     Abstract available


  28. LIU S, Feng F, Xu G, Liu Z, et al
    Clinicopathological features and prognosis of gastric cancer in young patients.
    BMC Cancer. 2016;16:478.
    PubMed     Text format     Abstract available


  29. GUO H, Xia B
    Collapsin response mediator protein 4 isoforms (CRMP4a and CRMP4b) have opposite effects on cell proliferation, migration, and invasion in gastric cancer.
    BMC Cancer. 2016;16:565.
    PubMed     Text format     Abstract available


  30. ZHAO JH, Gao P, Song YX, Sun JX, et al
    Which is better for gastric cancer patients, perioperative or adjuvant chemotherapy: a meta-analysis.
    BMC Cancer. 2016;16:631.
    PubMed     Text format     Abstract available


  31. LICHTHARDT S, Kerscher A, Dietz UA, Jurowich C, et al
    Original article: role of adjuvant chemotherapy in a perioperative chemotherapy regimen for gastric cancer.
    BMC Cancer. 2016;16:650.
    PubMed     Text format     Abstract available


  32. WANG T, Fei HJ, Yang Y, Jiang XS, et al
    Expression of AE1/p16 promoted degradation of AE2 in gastric cancer cells.
    BMC Cancer. 2016;16:716.
    PubMed     Text format     Abstract available


  33. ZOU K, Yang S, Zheng L, Yang C, et al
    Efficacy and safety of target combined chemotherapy in advanced gastric cancer: a meta-analysis and system review.
    BMC Cancer. 2016;16:737.
    PubMed     Text format     Abstract available


    May 2015
  34. GAO W, Xu J, Wang F, Zhang L, et al
    Plasma membrane proteomic analysis of human Gastric Cancer tissues: revealing flotillin 1 as a marker for Gastric Cancer.
    BMC Cancer. 2015;15:367.
    PubMed     Text format     Abstract available


  35. LI P, He HQ, Zhu CM, Ling YH, et al
    The prognostic significance of lymphovascular invasion in patients with resectable gastric cancer: a large retrospective study from Southern China.
    BMC Cancer. 2015;15:370.
    PubMed     Text format     Abstract available


  36. WANG X, Li Y, Xu G, Liu M, et al
    Mechanism study of peptide GMBP1 and its receptor GRP78 in modulating gastric cancer MDR by iTRAQ-based proteomic analysis.
    BMC Cancer. 2015;15:358.
    PubMed     Text format     Abstract available


  37. HUR H, Lee HY, Lee HJ, Kim MC, et al
    Efficacy of laparoscopic subtotal gastrectomy with D2 lymphadenectomy for locally advanced gastric cancer: the protocol of the KLASS-02 multicenter randomized controlled clinical trial.
    BMC Cancer. 2015;15:355.
    PubMed     Text format     Abstract available


  38. CHANG Y, Cho B, Son KY, Shin DW, et al
    Determinants of gastric cancer screening attendance in Korea: a multi-level analysis.
    BMC Cancer. 2015;15:336.
    PubMed     Text format     Abstract available


    April 2015
  39. SUN C, Fukui H, Hara K, Zhang X, et al
    FGF9 from cancer-associated fibroblasts is a possible mediator of invasion and anti-apoptosis of gastric cancer cells.
    BMC Cancer. 2015;15:333.
    PubMed     Text format     Abstract available


    February 2015
  40. LI-CHANG HH, Kasaian K, Ng Y, Lum A, et al
    Retrospective review using targeted deep sequencing reveals mutational differences between gastroesophageal junction and gastric carcinomas.
    BMC Cancer. 2015;15:32.
    PubMed     Text format     Abstract available


    January 2015
  41. HE X, Li B, Shao Y, Zhao N, et al
    Cell fusion between gastric epithelial cells and mesenchymal stem cells results in epithelial-to-mesenchymal transition and malignant transformation.
    BMC Cancer. 2015;15:24.
    PubMed     Text format     Abstract available


  42. KAWASAKI Y, Ishigami S, Arigami T, Uenosono Y, et al
    Clinicopathological significance of nuclear factor (erythroid-2)-related factor 2 (Nrf2) expression in gastric cancer.
    BMC Cancer. 2015;15:5.
    PubMed     Text format     Abstract available


  43. PARK JH, Ryu MH, Park YS, Park SR, et al
    Successful control of heavily pretreated metastatic gastric cancer with the mTOR inhibitor everolimus (RAD001) in a patient with PIK3CA mutation and pS6 overexpression.
    BMC Cancer. 2015;15:1139.
    PubMed     Text format     Abstract available


  44. LIN CN, Wang CJ, Chao YJ, Lai MD, et al
    The significance of the co-existence of osteopontin and tumor-associated macrophages in gastric cancer progression.
    BMC Cancer. 2015;15:1114.
    PubMed     Text format     Abstract available


  45. CHEN H, Guan R, Lei Y, Chen J, et al
    Lymphangiogenesis in Gastric Cancer regulated through Akt/mTOR-VEGF-C/VEGF-D axis.
    BMC Cancer. 2015;15:1109.
    PubMed     Text format     Abstract available


  46. YANG X, Sun HJ, Li ZR, Zhang H, et al
    Gastric cancer-associated enhancement of von Willebrand factor is regulated by vascular endothelial growth factor and related to disease severity.
    BMC Cancer. 2015;15:1083.
    PubMed     Text format     Abstract available


  47. YANG X, Sun HJ, Li ZR, Zhang H, et al
    Gastric cancer-associated enhancement of von Willebrand factor is regulated by vascular endothelial growth factor and related to disease severity.
    BMC Cancer. 2015;15:80.
    PubMed     Text format     Abstract available


  48. PARK JH, Ryu MH, Park YS, Park SR, et al
    Successful control of heavily pretreated metastatic gastric cancer with the mTOR inhibitor everolimus (RAD001) in a patient with PIK3CA mutation and pS6 overexpression.
    BMC Cancer. 2015;15:119.
    PubMed     Text format     Abstract available


  49. CHEN H, Guan R, Lei Y, Chen J, et al
    Lymphangiogenesis in Gastric Cancer regulated through Akt/mTOR-VEGF-C/VEGF-D axis.
    BMC Cancer. 2015;15:103.
    PubMed     Text format     Abstract available


  50. LIN CN, Wang CJ, Chao YJ, Lai MD, et al
    The significance of the co-existence of osteopontin and tumor-associated macrophages in gastric cancer progression.
    BMC Cancer. 2015;15:128.
    PubMed     Text format     Abstract available


  51. ZHOU C, Ji J, Cai Q, Shi M, et al
    MTA2 enhances colony formation and tumor growth of gastric cancer cells through IL-11.
    BMC Cancer. 2015;15:343.
    PubMed     Text format     Abstract available


  52. SAEKI N, Komatsuzaki R, Chiwaki F, Yanagihara K, et al
    A GSDMB enhancer-driven HSV thymidine kinase-expressing vector for controlling occult peritoneal dissemination of gastric cancer cells.
    BMC Cancer. 2015;15:439.
    PubMed     Text format     Abstract available


  53. HO AL, Szulakowsi P, Mohamid WH
    The diagnostic challenge of pulmonary tumour thrombotic microangiopathy as a presentation for metastatic gastric cancer: a case report and review of the literature.
    BMC Cancer. 2015;15:450.
    PubMed     Text format     Abstract available


  54. PAK KH, Jo A, Choi HJ, Choi Y, et al
    The different role of intratumoral and peritumoral lymphangiogenesis in gastric cancer progression and prognosis.
    BMC Cancer. 2015;15:498.
    PubMed     Text format     Abstract available


  55. LEONG T, Smithers BM, Michael M, Gebski V, et al
    TOPGEAR: a randomised phase III trial of perioperative ECF chemotherapy versus preoperative chemoradiation plus perioperative ECF chemotherapy for resectable gastric cancer (an international, intergroup trial of the AGITG/TROG/EORTC/NCIC CTG).
    BMC Cancer. 2015;15:532.
    PubMed     Text format     Abstract available


  56. ROCHA GA, Rocha AM, Gomes AD, Faria CL Jr, et al
    STAT3 polymorphism and Helicobacter pylori CagA strains with higher number of EPIYA-C segments independently increase the risk of gastric cancer.
    BMC Cancer. 2015;15:528.
    PubMed     Text format     Abstract available


  57. HAVERKAMP L, Brenkman HJ, Seesing MF, Gisbertz SS, et al
    Laparoscopic versus open gastrectomy for gastric cancer, a multicenter prospectively randomized controlled trial (LOGICA-trial).
    BMC Cancer. 2015;15:556.
    PubMed     Text format     Abstract available


  58. SUBHASH VV, Tan SH, Tan WL, Yeo MS, et al
    GTSE1 expression represses apoptotic signaling and confers cisplatin resistance in gastric cancer cells.
    BMC Cancer. 2015;15:550.
    PubMed     Text format     Abstract available


  59. HO AL, Szulakowski P, Mohamid WH
    Erratum to: The diagnostic challenge of pulmonary tumour thrombotic microangiopathy as a presentation for metastatic gastric cancer: A case report and review of the literature.
    BMC Cancer. 2015;15:600.
    PubMed     Text format    


  60. LI D, Zhang J, Xi Y, Zhang L, et al
    Mitogen-activated protein kinase activator with WD40 repeats (MAWD) and MAWD-binding protein induce cell differentiation in gastric cancer.
    BMC Cancer. 2015;15:637.
    PubMed     Text format     Abstract available


  61. HE J, Shi H, Zhou Z, Chen J, et al
    Correlation between apparent diffusion coefficients and HER2 status in gastric cancers: pilot study.
    BMC Cancer. 2015;15:749.
    PubMed     Text format     Abstract available


  62. LI L, Gan Y, Wu C, Qu X, et al
    Coffee consumption and the risk of gastric cancer: a meta-analysis of prospective cohort studies.
    BMC Cancer. 2015;15:733.
    PubMed     Text format     Abstract available


  63. TAKAHASHI H, Kaniwa N, Saito Y, Sai K, et al
    Construction of possible integrated predictive index based on EGFR and ANXA3 polymorphisms for chemotherapy response in fluoropyrimidine-treated Japanese gastric cancer patients using a bioinformatic method.
    BMC Cancer. 2015;15:718.
    PubMed     Text format     Abstract available


  64. BOCCARDI V, Marano L, Rossetti RR, Rizzo MR, et al
    Serum CD26 levels in patients with gastric cancer: a novel potential diagnostic marker.
    BMC Cancer. 2015;15:703.
    PubMed     Text format     Abstract available


  65. XUE J, Zhu Y, Sun Z, Ji R, et al
    Tumorigenic hybrids between mesenchymal stem cells and gastric cancer cells enhanced cancer proliferation, migration and stemness.
    BMC Cancer. 2015;15:793.
    PubMed     Text format     Abstract available


  66. LIU X, Liu J, Qiu H, Kong P, et al
    Prognostic significance of Epstein-Barr virus infection in gastric cancer: a meta-analysis.
    BMC Cancer. 2015;15:782.
    PubMed     Text format     Abstract available


  67. WANG Z, Liu H, Shen Z, Wang X, et al
    The prognostic value of CXC-chemokine receptor 2 (CXCR2) in gastric cancer patients.
    BMC Cancer. 2015;15:766.
    PubMed     Text format     Abstract available


  68. ZHU Y, Tian T, Zou J, Wang Q, et al
    Dual PI3K/mTOR inhibitor BEZ235 exerts extensive antitumor activity in HER2-positive gastric cancer.
    BMC Cancer. 2015;15:894.
    PubMed     Text format     Abstract available


  69. LIU Z, Guo J, Wang S, Zhao Y, et al
    Evaluation of transabdominal ultrasound after oral administration of an echoic cellulose-based gastric ultrasound contrast agent for gastric cancer.
    BMC Cancer. 2015;15:932.
    PubMed     Text format     Abstract available


  70. YOLANDA LV, Sergio PD, Hugo ES, Isabel AF, et al
    Gastric cancer progression associated with local humoral immune responses.
    BMC Cancer. 2015;15:924.
    PubMed     Text format     Abstract available


  71. NAKAGAWA M, Choi YY, An JY, Chung H, et al
    Difficulty of predicting the presence of lymph node metastases in patients with clinical early stage gastric cancer: a case control study.
    BMC Cancer. 2015;15:943.
    PubMed     Text format     Abstract available


  72. SU HJ, Zhang Y, Zhang L, Ma JL, et al
    Methylation status of COX-2 in blood leukocyte DNA and risk of gastric cancer in a high-risk Chinese population.
    BMC Cancer. 2015;15:979.
    PubMed     Text format     Abstract available


  73. LI XW, Shi BY, Yang QL, Wu J, et al
    Epigenetic regulation of CDH1 exon 8 alternative splicing in gastric cancer.
    BMC Cancer. 2015;15:954.
    PubMed     Text format     Abstract available


  74. LEE JW, Ali B, Yoo HM, Park CH, et al
    Conditional survival analysis in Korean patients with gastric cancer undergoing curative gastrectomy.
    BMC Cancer. 2015;15:1005.
    PubMed     Text format     Abstract available


  75. SEYFRIED F, von Rahden BH, Miras AD, Gasser M, et al
    Incidence, time course and independent risk factors for metachronous peritoneal carcinomatosis of gastric origin--a longitudinal experience from a prospectively collected database of 1108 patients.
    BMC Cancer. 2015;15:73.
    PubMed     Text format     Abstract available


  76. FU T, Bu ZD, Li ZY, Zhang LH, et al
    Neoadjuvant chemoradiation therapy for resectable esophago-gastric adenocarcinoma: a meta-analysis of randomized clinical trials.
    BMC Cancer. 2015;15:322.
    PubMed     Text format     Abstract available


  77. LI K, Du H, Lian X, Chai D, et al
    Establishment and characterization of a metastasis model of human gastric cancer in nude mice.
    BMC Cancer. 2016;16:54.
    PubMed     Text format     Abstract available


  78. PAK KH, Kim DH, Kim H, Lee do H, et al
    Differences in TGF-beta1 signaling and clinicopathologic characteristics of histologic subtypes of gastric cancer.
    BMC Cancer. 2016;16:60.
    PubMed     Text format     Abstract available


  79. DORES GM, Qubaiah O, Mody A, Ghabach B, et al
    A population-based study of incidence and patient survival of small cell carcinoma in the United States, 1992-2010.
    BMC Cancer. 2015;15:185.
    PubMed     Text format     Abstract available


  80. GONG J, Liu T, Fan Q, Bai L, et al
    Optimal regimen of trastuzumab in combination with oxaliplatin/ capecitabine in first-line treatment of HER2-positive advanced gastric cancer (CGOG1001): a multicenter, phase II trial.
    BMC Cancer. 2016;16:68.
    PubMed     Text format     Abstract available


  81. SATO Y, Kubo T, Morimoto K, Yanagihara K, et al
    High mannose-binding Pseudomonas fluorescens lectin (PFL) downregulates cell surface integrin/EGFR and induces autophagy in gastric cancer cells.
    BMC Cancer. 2016;16:63.
    PubMed     Text format     Abstract available


  82. PAK KH, Kim DH, Kim H, Lee do H, et al
    Erratum to: Differences in TGF-beta1 signaling and clinicopathologic characteristics of histologic subtypes of gastric cancer.
    BMC Cancer. 2016;16:99.
    PubMed     Text format    


  83. CARDOSO AP, Pinto ML, Pinto AT, Pinto MT, et al
    Matrix metalloproteases as maestros for the dual role of LPS- and IL-10-stimulated macrophages in cancer cell behaviour.
    BMC Cancer. 2015;15:456.
    PubMed     Text format     Abstract available


    December 2014
  84. WU B, Li T, Cai J, Xu Y, et al
    Cost-effectiveness analysis of adjuvant chemotherapies in patients presenting with gastric cancer after D2 gastrectomy.
    BMC Cancer. 2014;14:984.
    PubMed     Text format     Abstract available


  85. HAN Y, Ye J, Wu D, Wu P, et al
    LEIGC long non-coding RNA acts as a tumor suppressor in gastric carcinoma by inhibiting the epithelial-to-mesenchymal transition.
    BMC Cancer. 2014;14:932.
    PubMed     Text format     Abstract available


  86. YAN LH, Wei WY, Cao WL, Zhang XS, et al
    Overexpression of E2F1 in human gastric carcinoma is involved in anti-cancer drug resistance.
    BMC Cancer. 2014;14:904.
    PubMed     Text format     Abstract available


    November 2014
  87. QIU M, Zhou Y, Zhang X, Wang Z, et al
    Lauren classification combined with HER2 status is a better prognostic factor in Chinese gastric cancer patients.
    BMC Cancer. 2014;14:823.
    PubMed     Text format     Abstract available


    July 2014
  88. THOMAIDIS T, Maderer A, Al-Batran SE, Kany J, et al
    VEGFR-3 and CXCR4 as predictive markers for treatment with fluorouracil, leucovorin plus either oxaliplatin or cisplatin in patients with advanced esophagogastric cancer: a comparative study of the Arbeitsgemeinschaft Internistische Onkologie (AIO).
    BMC Cancer. 2014;14:476.
    PubMed     Text format     Abstract available


    January 2014
  89. GOERE D, Gras-Chaput N, Auperin A, Flament C, et al
    Treatment of gastric peritoneal carcinomatosis by combining complete surgical resection of lesions and intraperitoneal immunotherapy using catumaxomab.
    BMC Cancer. 2014;14:148.
    PubMed     Text format     Abstract available


  90. XU H, Shen Z, Xiao J, Yang Y, et al
    Acetylcholinesterase overexpression mediated by oncolytic adenovirus exhibited potent anti-tumor effect.
    BMC Cancer. 2014;14:668.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: